Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement-Reference-Cited by-同舟云学术

Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement

Published:2010-11-28 Issue:3 Volume:56 Page:353-360
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Jayanthan Aarthi,Incoronato Andrea,Singh Anjali,Blackmore Christopher,Bernoux Delphine,Lewis Victor,Stam Ronald,Whitlock James. A.,Narendran Aru

Funder

Alberta Children's Hospital Research Institute for Child and Maternal Health (ACHRI); Kids Cancer Care Foundation of Alberta (KCCFA); Edward J Brown Endowment for Leukemia Research

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22760/fullpdf

Reference45 articles.

1. Risk-adapted treatment of pediatric acute lymphoblastic leukemia;Jeha;Hematol Oncol Clin North Am,2009

2. Incidence of cancer in children in the United States: Sex-, race-, and 1-year age-specific rates by histologic types;Gurney;Cancer,1995

3. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group;Reaman;J Clin Oncol,1999

4. Biological and therapeutic aspects of infant leukemia;Biondi;Blood,2000

5. Body composition during growth: In vivo measurements and biochemical data correlated to differential anatomical growth;Friis-Hansen;Pediatrics,1971

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia;Hemato;2023-12-26

2. Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy;Leukemia;2022-11-15

3. Neonatal Leukemia;Clinics in Perinatology;2021-03

4. Dysregulation of BCL-2 family proteins by leukemia fusion genes;Journal of Biological Chemistry;2017-09

5. Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice;Cell Death & Disease;2016-09